TY - JOUR T1 - Correction to “Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution” JF - Pharmacological Reviews JO - Pharmacol Rev SP - 605 LP - 605 DO - 10.1124/pr.119.018440err VL - 72 IS - 3 A2 - , Y1 - 2020/07/01 UR - http://pharmrev.aspetjournals.org/content/72/3/605.abstract N2 - ER -